Medicine and Dentistry
Bexarotene
58%
Cutaneous T Cell Lymphoma
50%
Neoplasm
33%
Leukocyte
33%
Cells
33%
Patient
25%
Lymphoma Cell
16%
Serum
8%
Diseases
8%
Biological Marker
8%
Combination Therapy
8%
Immunocompetent Cell
8%
Monotherapy
8%
Event Free Survival
8%
Granulysin
8%
Phototherapy
8%
Skin
8%
Marker
8%
Inpatient
8%
Microscopy
8%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
CD25
25%
CCR4
16%
CCL22
16%
Immunocompetent Cell
8%
Regulatory T Cell
8%
CD8+ Cell
8%
Microscopy
8%
Cytotoxic T Cell
8%
Event Free Survival
8%
Immunology and Microbiology
Tumor-Associated Macrophage
33%
Cells
33%
CD25
25%
Lymphoma Cell
16%
CCR4
16%
CCL22
16%
Regulatory T Cell
8%
Cytotoxic T Cell
8%
Immunocompetent Cell
8%
Event Free Survival
8%
CD8+ Cell
8%
Granulysin
8%
Skin
8%
Pharmacology, Toxicology and Pharmaceutical Science
Bexarotene
58%
Cutaneous T Cell Lymphoma
50%
Neoplasm
33%
Diseases
8%
Biological Marker
8%
Monotherapy
8%
Event Free Survival
8%
Granulysin
8%
Veterinary Science and Veterinary Medicine
Leukocytes
33%
CD8+ Cell
8%
Cytotoxic T Cell
8%
Regulatory T Cell
8%